November 14, 2013
Eli Lilly & Co. hit generic drugmaker Actavis Inc. and its subsidiaries with a suit Tuesday in Indiana federal court claiming that the company infringed six patents covering Eli Lilly's Axiron, a topical treatment used by men afflicted with low testosterone.